MedTrace Logo

Assessment of Fluticasone Propionate on Ocular Allergy Symptoms

NCT01817790 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 626

Last updated 2014-04-03

Study results available
· View outcomes & findings →

Summary

This study is designed to investigate the efficacy of fluticasone propionate (FP) on ocular symptoms associated with allergic rhinitis (AR).

Conditions

  • Allergic Rhinitis
  • Seasonal Allergic Rhinitis

Interventions

DRUG

Fluticasone propionate

Nasal spray formulation (200 mcg/day)

DRUG

Placebo

Vehicle for Fluticasone propionate aqueous nasal spray

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01817790 on ClinicalTrials.gov